These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 735734)

  • 1. Chlorpromazine in the blood of schizophrenics.
    Sikora J; Krulík R; Král J; Novotný J
    Act Nerv Super (Praha); 1978 Dec; 20(4):278-80. PubMed ID: 735734
    [No Abstract]   [Full Text] [Related]  

  • 2. [Free amino acids and the total middle molecule fraction of the blood serum in patients with continuously progressive paranoid schizophrenia undergoing treatment].
    Mishanich II; Turianitsa IM; Pashchenko AE; Rostoka LM; Iliushina SN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):107-10. PubMed ID: 3364087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma levels of various catecholamines in schizophrenic patients during treatment with chlorpromazine].
    Olajossy M; Solski J; Ksiazek A
    Psychiatr Pol; 1987; 21(3):246-50. PubMed ID: 3423147
    [No Abstract]   [Full Text] [Related]  

  • 4. Loxapine versus chlorpromazine in paranoid schizophrenia: a double-blind study.
    Tuason VB; Escobar JI; Garvey M; Schiele B
    J Clin Psychiatry; 1984 Apr; 45(4):158-63. PubMed ID: 6370967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electroencephalographic profile and dynamics of individual changes in the EEG of paranoid schizophrenics during treatment with aminazine (clinico-electroencephalographic correlation)].
    Bochkarov VK; Nikiforov AI; Tsirkin SIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1192-9. PubMed ID: 7315055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Middle-molecule spectrum of the blood serum in patients with a continuously progressive paranoid form of schizophrenia undergoing treatment].
    Turianitsa IM; Mishanich II; Rostoka LM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(5):109-11. PubMed ID: 3414260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chlorpromazine on the pituitary-adrenal functions evaluated with insulin tolerance test and dexamethasone suppression test in patients with paranoid schizophrenia.
    Horodnicki JM; Pobocha J; Czekalski S
    Act Nerv Super (Praha); 1989 Apr; 31(1):46-8. PubMed ID: 2675525
    [No Abstract]   [Full Text] [Related]  

  • 8. Chlorpromazine excretion. III. Fecal excretion of 14C-chlorpromzine in chronically dosed patients.
    Georgotas A; Serra MT; Green DE; Perel JM; Gershon S; Forrest IS
    Commun Psychopharmacol; 1979; 3(3):197-202. PubMed ID: 498751
    [No Abstract]   [Full Text] [Related]  

  • 9. Nursing care study: paranoid schizophrenia.
    Stevens P
    Nurs Mirror Midwives J; 1976 Apr; 142(16):49-51. PubMed ID: 1046217
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia].
    Termińska K; Mrowiec W
    Psychiatr Pol; 1989; 23(1):24-30. PubMed ID: 2573098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of intensive hospital treatment on the duration of remissions among schizophrenics with a long history of the disease].
    Malakhov BB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):564-8. PubMed ID: 4267491
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of 4 weeks treatment with chlorpromazine and/or trihexyphenidyl on the pituitary-gonadal axis in male paranoid schizophrenics.
    Rinieris P; Hatzimanolis J; Markianos M; Stefanis C
    Eur Arch Psychiatry Neurol Sci; 1988; 237(4):189-93. PubMed ID: 3203697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A controlled study of clinical therapeutic effects of laser acupuncture for schizophrenia].
    Zhang B
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Apr; 24(2):81-3, 124. PubMed ID: 1860386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of paranoid schizophrenics with chlorpromazine and group therapy.
    Borowski T; Tolwinski T
    Dis Nerv Syst; 1969 Mar; 30(3):201-2. PubMed ID: 5774344
    [No Abstract]   [Full Text] [Related]  

  • 15. ABO blood group distribution in hebephrenic and paranoid schizophrenics. Preliminary data.
    Maj M; Morgese G; Del Vecchio M; Kemali D
    Acta Neurol (Napoli); 1980 Oct; 2(5):394-8. PubMed ID: 7457218
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical significance of pattern of blood chlorpromazine and its metabolite levels and prediction of response to chlorpromazine treatment--studies on the rational pharmacotherapy in schizophrenics (author's transl)].
    Sakurai Y; Nakahara T; Ikenaga H; Takahashi R
    Seishin Shinkeigaku Zasshi; 1978 Jul; 80(7):405-24. PubMed ID: 724820
    [No Abstract]   [Full Text] [Related]  

  • 17. Paranoid schizophrenia. A serpent which licked my eyes..
    Hansford M
    Nurs Mirror; 1981 May; 152(19):30-3. PubMed ID: 6909921
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relationship between plasma thioridazine level and the symptoms of paranoid schizophrenia].
    Afeltowicz Z
    Psychiatr Pol; 1979; 13(3):223-33. PubMed ID: 472063
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antibodies to neuroleptics and their role in the mechanisms of the development of drug resistance in psychopharmacotherapy of patients with paranoid schizophrenia].
    Govorin NV; Lozhkina AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(7):117-21. PubMed ID: 1661466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Level of free and bound chlorpromazine fractions in the blood and urine during chlorpromazine treatment].
    Nurowska K; Szajbel W; Waszkiewicz E; Welbel L
    Psychiatr Pol; 1970; 4(4):435-42. PubMed ID: 5472581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.